GLP-2 administration in ovariectomized mice enhances collagen maturity but did not improve bone strength.

Bone composition Bone remodeling Bone strength GLP-2 Infrared imaging

Journal

Bone reports
ISSN: 2352-1872
Titre abrégé: Bone Rep
Pays: United States
ID NLM: 101646176

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 28 11 2019
revised: 03 02 2020
accepted: 04 02 2020
entrez: 20 2 2020
pubmed: 20 2 2020
medline: 20 2 2020
Statut: epublish

Résumé

Osteoporosis and bone fragility are progressing worldwide. Previous published literature reported a possible beneficial role of gut hormones, and especially glucagon-like peptide-2 (GLP-2), in modulating bone remodeling. As now (Gly

Identifiants

pubmed: 32071954
doi: 10.1016/j.bonr.2020.100251
pii: S2352-1872(20)30010-3
pii: 100251
pmc: PMC7013338
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100251

Informations de copyright

© 2020 The Authors.

Déclaration de conflit d'intérêts

None of the authors have any conflict of interest to report.

Références

Neuro Endocrinol Lett. 2001 Apr;22(2):121-7
pubmed: 11335888
Bone. 2015 May;74:29-36
pubmed: 25582623
J Bone Miner Res. 2013 Jan;28(1):2-17
pubmed: 23197339
J Clin Endocrinol Metab. 1995 Nov;80(11):3304-10
pubmed: 7593443
Bone. 2011 Nov;49(5):955-64
pubmed: 21810491
J Bone Miner Res. 2001 May;16(5):893-900
pubmed: 11341334
Am J Med. 2013 Jan;126(1):13-20
pubmed: 23177553
Calcif Tissue Int. 2002 May;70(5):422-9
pubmed: 12055658
J Bone Miner Res. 2010 Jul;25(7):1468-86
pubmed: 20533309
Bone. 2014 Jun;63:61-8
pubmed: 24594344
Mol Biol Cell. 2004 Aug;15(8):3673-87
pubmed: 15169869
Bonekey Rep. 2013 Dec 04;2:447
pubmed: 24501681
Compr Physiol. 2018 Jun 18;8(3):1185-1210
pubmed: 29978894
J Biol Chem. 1993 May 15;268(14):10345-50
pubmed: 8098038
Bone. 2009 Nov;45(5):833-42
pubmed: 19631303
Bone. 1993 Jul-Aug;14(4):595-608
pubmed: 8274302
J Clin Endocrinol Metab. 2000 Aug;85(8):2884-8
pubmed: 10946898
J Biol Chem. 2005 Jun 10;280(23):22124-34
pubmed: 15817468
N Engl J Med. 2001 May 10;344(19):1434-41
pubmed: 11346808
Basic Appl Histochem. 1983;27(2):75-85
pubmed: 6193776
JAMA. 1999 Aug 18;282(7):637-45
pubmed: 10517716
J Bone Miner Res. 2007 Sep;22(9):1419-25
pubmed: 17547534
J Musculoskelet Neuronal Interact. 2015 Mar;15(1):42-52
pubmed: 25730651
Bone. 2013 Mar;53(1):221-30
pubmed: 23220186
Gut. 2011 Jul;60(7):902-14
pubmed: 21317170
J Bone Miner Res. 1994 Dec;9(12):1883-8
pubmed: 7872053
J Endocrinol. 2013 Sep 06;219(1):59-68
pubmed: 23911987
Bone. 2008 Nov;43(5):794-7
pubmed: 18672104
J Clin Endocrinol Metab. 1998 Mar;83(3):751-6
pubmed: 9506720
N Engl J Med. 2009 Aug 20;361(8):756-65
pubmed: 19671655
Clin Chem. 1999 Oct;45(10):1858-60
pubmed: 10508135
J Bone Miner Res. 2001 Oct;16(10):1821-8
pubmed: 11585346
Life Sci. 2019 Jun 1;226:47-56
pubmed: 30959027
Eur J Endocrinol. 1999 Apr;140(4):332-7
pubmed: 10097253
Calcif Tissue Int. 2015 Jan;96(1):18-29
pubmed: 25424977
J Clin Invest. 2017 Dec 1;127(12):4217-4227
pubmed: 29202475
Osteoporos Int. 2011 Aug;22(8):2225-40
pubmed: 21347743
Calcif Tissue Int. 1996 Jan;58(1):9-16
pubmed: 8825233
Calcif Tissue Int. 2017 Apr;100(4):332-340
pubmed: 28160025
Cell Prolif. 2018 Aug;51(4):e12443
pubmed: 29457300
J Bone Miner Res. 2003 Dec;18(12):2180-9
pubmed: 14672353
J Clin Pharmacol. 2010 Jan;50(1):36-49
pubmed: 19773525
Bone. 1998 Jan;22(1):73-8
pubmed: 9437516
Bone. 2008 Oct;43(4):717-23
pubmed: 18639658
Bone. 1998 Oct;23(4):319-26
pubmed: 9763143
Bone. 2013 Oct;56(2):337-42
pubmed: 23851294
Bone. 2004 Jan;34(1):140-7
pubmed: 14751571
J Clin Endocrinol Metab. 2012 Jul;97(7):2272-82
pubmed: 22523337
Diabetologia. 2008 Jun;51(6):1035-40
pubmed: 18389210
Bone. 2007 Mar;40(3):723-9
pubmed: 17081815
Am J Med. 1993 Jun;94(6):646-50
pubmed: 8506892
Nat Protoc. 2013;8(7):1433-48
pubmed: 23807286
Morphologie. 2017 Mar;101(332):9-18
pubmed: 27423214
J Bone Miner Res. 2015 Jun;30(6):951-66
pubmed: 25917136

Auteurs

B Gobron (B)

Groupe études remodelage osseux et biomatériaux, GEROM, UPRES EA4658, UNIV Angers, SFR 42-08, Institut de Biologie en Santé, CHU d'Angers, 49933 Angers cedex, France.
Service de Rhumatologie, CHU d'Angers, 49933 Angers cedex, France.

B Bouvard (B)

Groupe études remodelage osseux et biomatériaux, GEROM, UPRES EA4658, UNIV Angers, SFR 42-08, Institut de Biologie en Santé, CHU d'Angers, 49933 Angers cedex, France.
Service de Rhumatologie, CHU d'Angers, 49933 Angers cedex, France.

E Legrand (E)

Groupe études remodelage osseux et biomatériaux, GEROM, UPRES EA4658, UNIV Angers, SFR 42-08, Institut de Biologie en Santé, CHU d'Angers, 49933 Angers cedex, France.
Service de Rhumatologie, CHU d'Angers, 49933 Angers cedex, France.

D Chappard (D)

Groupe études remodelage osseux et biomatériaux, GEROM, UPRES EA4658, UNIV Angers, SFR 42-08, Institut de Biologie en Santé, CHU d'Angers, 49933 Angers cedex, France.
Service commun d'imageries et d'analyses microscopiques, SCIAM, UNIV Angers, SFR 42-08, Institut de Biologie en Santé, CHU d'Angers, 49933 Angers cedex, France.
UF de Pathologie osseuse, CHU d'Angers, 49933 Angers cedex, France.

G Mabilleau (G)

Groupe études remodelage osseux et biomatériaux, GEROM, UPRES EA4658, UNIV Angers, SFR 42-08, Institut de Biologie en Santé, CHU d'Angers, 49933 Angers cedex, France.
Service commun d'imageries et d'analyses microscopiques, SCIAM, UNIV Angers, SFR 42-08, Institut de Biologie en Santé, CHU d'Angers, 49933 Angers cedex, France.
UF de Pathologie osseuse, CHU d'Angers, 49933 Angers cedex, France.

Classifications MeSH